Unmasking of incipient amyotrophic lateral sclerosis by botulinum toxin therapy.

Unmasking of incipient amyotrophic lateral sclerosis by botulinum toxin therapy.

Mostrar outras versões (1)

Detalhes bibliográficos
Principais autores:	Kent, L, Davies, P, Kennett, R, Wimalaratna, S, Kerr, R, Turner, M, Talbot, K
Formato:	Journal article
Idioma:	English
Publicado em:	2013

Registros relacionados

Unmasking of incipient amyotrophic lateral sclerosis by botulinum toxin therapy
por: Kent, L, et al.
Publicado em: (2013)

Botulinum Toxin Type A and Physiotherapy in Spasticity of the Lower Limbs Due to Amyotrophic Lateral Sclerosis
por: Riccardo Marvulli, et al.
Publicado em: (2019-07-01)

Application of botulinum toxin to treat sialorrhea in amyotrophic lateral sclerosis patients: a literature review
por: Ademar Francisco de Oliveira Filho, et al.

Biomarkers in amyotrophic lateral sclerosis.
por: Turner, M, et al.
Publicado em: (2009)

Sweet food preference in amyotrophic lateral sclerosis
por: Turner, M, et al.
Publicado em: (2017)

Psychiatric disorders prior to amyotrophic lateral sclerosis
por: Turner, M, et al.
Publicado em: (2016)

Myelin imaging in amyotrophic and primary lateral sclerosis.
por: Kolind, S, et al.
Publicado em: (2013)

Motor system biomarkers in amyotrophic lateral sclerosis
por: Edmond, EC, et al.
Publicado em: (2019)

Autoimmune disease preceding amyotrophic lateral sclerosis: an epidemiologic study.
por: Turner, M, et al.
Publicado em: (2013)

Quantitative FLAIR MRI in amyotrophic lateral sclerosis
por: Fabes, J, et al.
Publicado em: (2017)

CSF chitinase proteins in amyotrophic lateral sclerosis
por: Thompson, A, et al.
Publicado em: (2019)

The reunification of amyotrophic lateral sclerosis
por: Turner, M
Publicado em: (2018)

Progressive hemiparesis (Mills syndrome) with aphasia in amyotrophic lateral sclerosis.
por: Bäumer, D, et al.
Publicado em: (2014)

Genetics of sporadic amyotrophic lateral sclerosis.
por: Schymick, J, et al.
Publicado em: (2007)

Survival motor neuron deficiency enhances progression in an amyotrophic lateral sclerosis mouse model.
por: Turner, B, et al.
Publicado em: (2009)

Amyotrophic lateral sclerosis: the complex path to precision medicine
por: Talbot, K, et al.
Publicado em: (2018)

Amyotrophic lateral sclerosis.
por: Kiernan, M, et al.
Publicado em: (2011)

Oculomotor dysfunction in amyotrophic lateral sclerosis: a comprehensive review.
por: Sharma, R, et al.
Publicado em: (2011)

The Basis of Cognitive and Behavioral Dysfunction in Amyotrophic Lateral Sclerosis
por: Alexander Bampton, et al.
Publicado em: (2024-11-01)

The diagnostic pathway and prognosis in bulbar-onset amyotrophic lateral sclerosis.
por: Turner, M, et al.
Publicado em: (2010)

A case of celiac disease mimicking amyotrophic lateral sclerosis.
por: Turner, M, et al.
Publicado em: (2007)

Imaging Cerebral Activity in Amyotrophic Lateral Sclerosis
por: Malcolm Proudfoot, et al.
Publicado em: (2019-01-01)

The two-year progression of structural and functional cerebral MRI in amyotrophic lateral sclerosis
por: Menke, R, et al.
Publicado em: (2017)

The tough body at the epicentre of amyotrophic lateral sclerosis
por: Turner, M, et al.
Publicado em: (2017)

Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis
por: Thompson, A, et al.
Publicado em: (2018)

Neuroimaging endpoints in amyotrophic lateral sclerosis
por: Menke, R, et al.
Publicado em: (2016)

Amyotrophic lateral sclerosis: Cell vulnerability or system vulnerability?
por: Talbot, K
Publicado em: (2014)

Amyotrophic lateral sclerosis: cell vulnerability or system vulnerability?
por: Talbot, K
Publicado em: (2014)

Defective cholesterol metabolism in amyotrophic lateral sclerosis
por: Jonas Abdel-Khalik, et al.
Publicado em: (2017-01-01)

Survival motor neuron deficiency enhances progression in an amyotrophic lateral sclerosis mouse model
por: Bradley J. Turner, et al.
Publicado em: (2009-06-01)

Neuroimaging in amyotrophic lateral sclerosis.
por: Turner, M, et al.
Publicado em: (2012)

Gene Therapy in Amyotrophic Lateral Sclerosis
por: Ton Fang, et al.
Publicado em: (2022-06-01)

Gene therapy for amyotrophic lateral sclerosis
por: Thais Federici, et al.
Publicado em: (2012-11-01)

Controversies and priorities in amyotrophic lateral sclerosis.
por: Turner, M, et al.
Publicado em: (2013)

The longitudinal cerebrospinal fluid metabolomic profile of amyotrophic lateral sclerosis.
por: Gray, E, et al.
Publicado em: (2015)

The two-year progression of structural and functional cerebral MRI in amyotrophic lateral sclerosis
por: R.A.L. Menke, et al.
Publicado em: (2018-01-01)

Untangling neuroinflammation in amyotrophic lateral sclerosis
por: Thompson, AG, et al.
Publicado em: (2019)

Defective cholesterol metabolism in amyotrophic lateral sclerosis.
por: Abdel-Khalik, J, et al.
Publicado em: (2016)

Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations.
por: Bowser, R, et al.
Publicado em: (2011)

Regional callosal integrity and bilaterality of limb weakness in amyotrophic lateral sclerosis
por: Tu, S, et al.
Publicado em: (2020)